SIG Shares Sigma Healthcare Limited
BUY ASX · ASXStrong trading update, Chemist Warehouse exposure, and weight-loss-drug sales provide near-term earnings catalysts.
Future value: $3.20 (+17.15%) · 6-12 months · analyst consensus
Signal breakdown
- ▸Morgans buy rating and positive weight-loss-drug sales update
- ▸Above 50-day MA (+1.41%)
Is SIG a buy right now?
Trend: SIG is trading above the 50-day average (+1.86%), RSI 29 — oversold territory, with a 3-month return of -7.43%.
Valuation & quality: Sigma Healthcare Limited trades on a trailing P/E of 45.7, forward P/E 31.3, PEG 4.83, price-to-book 6.31; fundamentals show net margin 6.5%, return on equity 14.7%, revenue growth 31.9% year on year.
Analyst consensus: 16 analysts have a mean 12-month price target of A$3.15 (+15.3% vs the last close; range A$2.70 – A$3.75), consensus rating “buy”.
Income: trailing dividend yield 1.46%.
Our screen: BUY (score 3) — Strong trading update, Chemist Warehouse exposure, and weight-loss-drug sales provide near-term earnings catalysts.
Computed from end-of-day data; not personal advice.
Our track record with SIG
Our simulated $10,000 funds have traded SIG 1 time — 0 of 1 closed trade profitable.
| Fund | Bought | Sold | Return |
|---|---|---|---|
| ASX High-risk | 2026-09-01 @ $2.70 | 2026-09-03 @ $2.69 · AI review sell | -0.37% |
Paper trades from our simulated funds at real end-of-day prices; past results don't predict future returns.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| -3.90% | +2.20% | +5.40% | -6.50% | +6.90% | -8.50% | -3.70% | +5.80% |
Fundamentals
Analyst price target
Technical signals
About Sigma Healthcare Limited
Sigma Healthcare Limited operates as a retail pharmacy franchisor and pharmaceutical wholesale and distributor to community pharmacies in Australia, and internationally.
Sector: Healthcare · Industry: Medical Distribution · Australia · Website
Related Health Care picks
Browse: all ASX stocks · Health Care picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.